AI assistant
ELI LILLY & Co — Director's Dealing 2011
Dec 14, 2011
29745_dirs_2011-12-14_0ad6a00b-7944-4406-8451-30f827ad31bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2011-12-12
Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-12 | Common Stock | S | 5787 | $39.10 | Disposed | 51266 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6841 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011.
F2: This transaction was executed in multiple trades at prices ranging from $39.06 to $39.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.